Medtech Law & Policy - Clearing Up the Confusion on MDR: Where Do We Go From Here?

Update: 2023-02-09

Description

The last few months have brought a flurry of MDR regulatory and legislative activity, causing a morass of confusion. In this interview, leading EU medtech lawyer Erik Vollebregt clarifies what the recent spate of proposals and guidances mean for product companies and how they should manage in these uncertain times, providing a look at what the future looks like for medtech regulation in Europe.

View the latest issue of Market Pathways: https://bit.ly/3M4gsLc

View more podcast episodes: https://bit.ly/3vgFTlT

About Market Pathways

Your premium guide to global medical device regulation, reimbursement and policy. Market Pathways delivers incomparable intelligence exploring the people, challenges, and opportunities impacting the global medtech regulatory and reimbursement community. View the latest issue of Market Pathways on MyStrategist.com

Comments

In Channel

Ep. 33: What Does it Mean to be a Reimbursement Professional?

2025-10-1632:37

Ep. 32: The Tariff Challenge, Policy Optimism, and The MedTech Conference With Scott Whitaker

2025-09-2245:37

EP 31: Haven’t We Heard This Song Before? Major EU Regulatory Changes on the Horizon

2025-07-2444:20

BTIG Weighs In on Whether Trump Policies Can Dent MedTech’s Healthy Run

2025-03-0729:54

Pioneering the Use of Real-World Evidence in Medtech: A Discussion with J&J’s Paul Coplan

2024-08-0101:06:17

FDA Inspections Getting Prepped and Avoiding Pitfalls

2024-05-2531:44

A VC’s View of the Reimbursement Evolution: An Interview with Mike Carusi

2024-03-2749:25

Reimbursement for Breakthrough Devices Still Lags—Need for TCET: An Interview with Josh Makower

2023-09-1956:25

Ep. 25: Medtech in China: An Island of Relative Calm in a Sea of Volatility

2023-08-1035:55